OR WAIT null SECS
February 19, 2020
The 135,000 square foot facility will be constructed over 18 months and is expected to be operational in 2021.
February 06, 2020
The new facility includes six classified environment rooms with space to expand.
February 02, 2020
Consider equipment design, transfer systems, and maintenance when operating isolators for sterile manufacturing of pharmaceutical products.
Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.
January 30, 2020
The new 1800-m2 building houses more than 50 employees and features non-GMP laboratory space and a GMP analytical laboratory.
January 29, 2020
The new facility, to be operated under the newly formed CDMO, The Center for Breakthrough Medicines, will be located in King of Prussia, PA, and will increase manufacturing capacity for cell and gene therapies.
January 27, 2020
The facility will produce parenteral products and delivery devices and is set to create 460 new jobs.
January 23, 2020
As the facility becomes fully operational, the company believes the potential risk of a shortage of the product due to increasing demand will be significantly reduced.
January 22, 2020
The fully integrated, pre-qualified, pre-installed aseptic filling facility can be shipped globally for drug development and the manufacturing of personalized medicines and clinical trial supplies.
The facility is now equipped to handle commercial manufacturing of a sterile injectable product in a pre-filled syringe presentation.